[Hormone therapy of metastasizing breast cancer with tamoxifen].
Out of 79 patients with metastasized carcinoma of the breast in 33% (6 patients) a response to a Tamoxifen therapy could be observed. For complete remissions the remission periods were 12.3 months, for partial remissions 9.9 months and in the group of constant findings 4.9 months. Preferably metastases of the soft parts respond to the therapy. The side effects are very insignificant. The indications for the tamoxifen therapy are represented as well as the importance of the determination of hormone receptors.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen
Die Hormontherapie des metastasierenden Mammakarzinoms mit Tamoxifen.